标题
The Beta Amyloid Dysfunction (BAD) Hypothesis for Alzheimer’s Disease
作者
关键词
-
出版物
Frontiers in Neuroscience
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-11-07
DOI
10.3389/fnins.2019.01154
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
- (2019) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer’s disease
- (2019) James A R Nicoll et al. BRAIN
- A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease
- (2019) Ebrima Gibbs et al. Scientific Reports
- Synaptic vesicle cycle and amyloid β: Biting the hand that feeds
- (2018) Saak V. Ovsepian et al. Alzheimers & Dementia
- Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6
- (2018) Kaichuan Zhu et al. BIOLOGICAL PSYCHIATRY
- The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
- (2018) Erika N. Cline et al. JOURNAL OF ALZHEIMERS DISEASE
- BACE1 as a Potential Biomarker for Alzheimer's Disease
- (2018) Boris Decourt et al. JOURNAL OF ALZHEIMERS DISEASE
- Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study
- (2018) Maarten Timmers et al. Alzheimers Research & Therapy
- BACE inhibitors in clinical development for the treatment of Alzheimer’s disease
- (2018) Francesco Panza et al. Expert Review of Neurotherapeutics
- The underexplored question of β-amyloid monomers
- (2017) Agata Copani EUROPEAN JOURNAL OF PHARMACOLOGY
- Not just amyloid: physiological functions of the amyloid precursor protein family
- (2017) Ulrike C. Müller et al. NATURE REVIEWS NEUROSCIENCE
- Pre-plaque conformational changes in Alzheimer’s disease-linked Aβ and APP
- (2017) O. Klementieva et al. Nature Communications
- Cell Biology and Pathophysiology of α-Synuclein
- (2017) Jacqueline Burré et al. Cold Spring Harbor Perspectives in Medicine
- AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer’s Disease
- (2016) Gvido Cebers et al. JOURNAL OF ALZHEIMERS DISEASE
- Neuritic and Diffuse Plaque Associations with Memory in Non-Cognitively Impaired Elderly
- (2016) Michael Malek-Ahmadi et al. JOURNAL OF ALZHEIMERS DISEASE
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity
- (2016) Levi M. Smith et al. Cold Spring Harbor Perspectives in Medicine
- Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
- (2015) Kaj Blennow et al. Alzheimers & Dementia
- Age and amyloid effects on human central nervous system amyloid-beta kinetics
- (2015) Bruce W. Patterson et al. ANNALS OF NEUROLOGY
- Label-free Quantitative Proteomics of Mouse Cerebrospinal Fluid Detects β-Site APP Cleaving Enzyme (BACE1) Protease Substrates In Vivo
- (2015) Bastian Dislich et al. MOLECULAR & CELLULAR PROTEOMICS
- Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly
- (2015) Takayuki Ohnishi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A highly sensitive novel immunoassay specifically detects low levels of soluble Aβ oligomers in human cerebrospinal fluid
- (2015) Ting Yang et al. Alzheimers Research & Therapy
- Intrinsically Disordered Proteins and Intrinsically Disordered Protein Regions
- (2014) Christopher J. Oldfield et al. Annual Review of Biochemistry
- α-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation
- (2014) Jacqueline Burré et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer’s Disease
- (2014) Natalia Salvadores et al. Cell Reports
- Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue
- (2013) Jun-Xia Lu et al. CELL
- Human APOE genotype affects intraneuronal A 1-42 accumulation in a lentiviral gene transfer model
- (2013) W. Zhao et al. HUMAN MOLECULAR GENETICS
- Increased Expression of Reticulon 3 in Neurons Leads to Reduced Axonal Transport of β Site Amyloid Precursor Protein-cleaving Enzyme 1
- (2013) Minzi Deng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fluid biomarkers in Alzheimer’s disease – current concepts
- (2013) Christoffer Rosén et al. Molecular Neurodegeneration
- Semagacestat for Treatment of Alzheimer's Disease
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody
- (2013) Gregory Antonios et al. Acta Neuropathologica Communications
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A Binding Properties Promotes Neuroprotection and Glial Engulfment of A
- (2012) O. Adolfsson et al. JOURNAL OF NEUROSCIENCE
- Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody
- (2012) Katherine L Youmans et al. Molecular Neurodegeneration
- Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease
- (2012) Sascha Weggen et al. Alzheimers Research & Therapy
- Calsyntenin-1 shelters APP from proteolytic processing during anterograde axonal transport
- (2012) M. Steuble et al. Biology Open
- Point Mutations in Aβ Result in the Formation of Distinct Polymorphic Aggregates in the Presence of Lipid Bilayers
- (2011) Phillip M. Pifer et al. PLoS One
- Generation and Therapeutic Efficacy of Highly Oligomer-Specific -Amyloid Antibodies
- (2010) H. Hillen et al. JOURNAL OF NEUROSCIENCE
- Decreased cerebrospinal fluid Aβ42correlates with brain atrophy in cognitively normal elderly
- (2009) Anne M. Fagan et al. ANNALS OF NEUROLOGY
- Structural Characterization of a Soluble Amyloid β-Peptide Oligomer
- (2009) Liping Yu et al. BIOCHEMISTRY
- β-Secretase-1 elevation in transgenic mouse models of Alzheimerâs disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development
- (2009) Xue-Mei Zhang et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Genetic and pharmacological evidence of intraneuronal Aβ accumulation in APP transgenic mice
- (2009) Ola Philipson et al. FEBS LETTERS
- -Amyloid Monomers Are Neuroprotective
- (2009) M. L. Giuffrida et al. JOURNAL OF NEUROSCIENCE
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
- (2009) Juha Laurén et al. NATURE
- Amyloid-β as a positive endogenous regulator of release probability at hippocampal synapses
- (2009) Efrat Abramov et al. NATURE NEUROSCIENCE
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
- (2008) Howard Jay Aizenstein et al. ARCHIVES OF NEUROLOGY
- Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease
- (2008) Henrik Zetterberg et al. ARCHIVES OF NEUROLOGY
- Amyloid Precursor Protein Trafficking, Processing, and Function
- (2008) Gopal Thinakaran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aβ-globulomers are formed independently of the fibril pathway
- (2008) Gerald P. Gellermann et al. NEUROBIOLOGY OF DISEASE
- Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo
- (2008) John R. Cirrito et al. NEURON
- Amyloid- Dynamics Correlate with Neurological Status in the Injured Human Brain
- (2008) D. L. Brody et al. SCIENCE
- Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease
- (2008) P. Hemachandra Reddy et al. TRENDS IN MOLECULAR MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started